nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

10.09.2017 | Letter to the Editor

Dosimetry in clinical radionuclide therapy: the devil is in the detail

verfasst von: Francesco Giammarile, Kristoff Muylle, Roberto Delgado Bolton, Jolanta Kunikowska, Uwe Haberkorn, Wim Oyen

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Excerpt

Radionuclide therapy (RNT), also known as “targeted”, “metabolic” or “molecular” radiotherapy, uses open (i.e. “unsealed”) radioactive isotopes, and is generally administered orally or intravenously, enabling delivery of a high radiation dose to the target, while minimizing toxicity to normal tissues. This systemic form of radiation therapy has distinct similarities to, but also profound differences from, the more commonly used external beam radiotherapy (EBRT). From another perspective, RNT can be better characterized as a tumour-selective treatment modality with more similarities to systemic chemotherapy [1]. …

Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen WJ, et al. Clinical radionuclide therapy dosimetry: the quest for the "holy gray". Eur J Nucl Med Mol Imaging. 2007;34(5):772–86.CrossRefPubMedPubMedCentral

Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Chouin N, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2017. https://doi.org/10.1007/s00259-017-3707-3.PubMedCentral

DeNardo GL, Juweid ME, White CA, Wiseman GA, DeNardo SJ. Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing. Crit Rev Oncol Hematol. 2001;39:203–18.CrossRefPubMed

Sandström M, Garske-Román U, Granberg D, Johansson S, Widström C, Eriksson B, et al. Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment. J Nucl Med. 2013;54(1):33–41.CrossRefPubMed

Pouget J-P, Mather SJ. General aspects of the cellular response to low- and high-LET radiation. Eur J Nucl Med. 2001;28:541–61.CrossRefPubMed

Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, et al. Radiation-induced biological bystander effect elicited in vitro by targeted radiopharmaceuticals labelled with α-, β-, and auger electron-emitting radionuclides. J Nucl Med. 2006;47:1007–15.PubMed

Granzotto A, Devic C, Viau M, Maalouf M, Joubert A, Massart C, et al. Individual susceptibility to radiosensitivity and to genomic instability: its impact on low- dose phenomena. Health Phys. 2011;100(3):282.CrossRefPubMed

Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol. 2012;13(1):65–77.CrossRefPubMed

Titel: Dosimetry in clinical radionuclide therapy: the devil is in the detail
verfasst von: Francesco Giammarile
Kristoff Muylle
Roberto Delgado Bolton
Jolanta Kunikowska
Uwe Haberkorn
Wim Oyen
Publikationsdatum: 10.09.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2017
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-017-3820-3

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Dosimetry in clinical radionuclide therapy: the devil is in the detail

Excerpt

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2017

The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

Early identification of MCI converting to AD: a FDG PET study

Bone SPECT/CT in the postoperative spine: a focus on spinal fusion

A new integrated dual time-point amyloid PET/MRI data analysis method

Quantification: there is more to worry about than good scanner hardware and reliable calibration